First AD

Second AD

Future Considerations for Polycythemia Vera Management: Takeaways from ASH 2024 

Video content above is prompted by the following:

What outstanding updates in PV from ASH 2024 are noteworthy? 

What do you see for the future of PV treatment?

How are ongoing investigational therapies helping to address these unmet needs?

What clinical pearls can you share for community oncologists?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care  

Peer Exchange

Panelists discuss noteworthy updates in polycythemia vera (PV) from ASH 2024, explore the future of PV treatment, highlight the greatest unmet needs, and discuss how ongoing investigational therapies aim to address these gaps. They also share clinical pearls for community oncologists in managing PV.